LCN2 mRNA expression was 20-fold upregulated in peripheral blood (PB) mononuclear cells of chronic myeloid leukemia (CML) and myelofibrosis (MF) patients vs. healthy controls. This evidence concerns the gene LCN2 and chronic myelogenous leukemia, BCR-ABL1 positive.